TypeDateAccessionPeriodSize
6-K
Mar 6, 2026
0001654954-26-001975FILING OF GSK PLC 2025 ANNUAL REPORT ON FORM 20-F
Mar 6, 2026
22.2 KB
IRANNOTICE
Mar 6, 2026
0001131399-26-000006IRANNOTICE
—
365.0 KB
20-F
Mar 6, 2026
0001131399-26-00000420-F
Dec 31, 2025
96.4 MB
6-K
Mar 6, 2026
0001654954-26-001950TRANSACTION IN OWN SHARES
Mar 6, 2026
9.3 MB
6-K
Mar 5, 2026
0001654954-26-001917GSK PUBLISHES ANNUAL REPORT 2025
Mar 5, 2026
21.4 KB
6-K
Mar 5, 2026
0001654954-26-001907TRANSACTION IN OWN SHARES
Mar 5, 2026
6.9 MB
6-K
Mar 4, 2026
0001654954-26-001860DIRECTOR/PDMR SHAREHOLDING
Mar 4, 2026
33.6 KB
6-K
Mar 4, 2026
0001654954-26-001852TRANSACTION IN OWN SHARES
Mar 4, 2026
8.9 MB
6-K
Mar 3, 2026
0001654954-26-001801GSK COMPLETES ACQUISITION OF RAPT THERAPEUTICS
Mar 3, 2026
37.4 KB
6-K
Mar 3, 2026
0001654954-26-001790TRANSACTION IN OWN SHARES
Mar 3, 2026
5.9 MB
SC TO-T/A
Mar 3, 2026
0001193125-26-086527SC TO-T/A
—
22.1 KB
6-K
Mar 2, 2026
0001654954-26-001756TRANSACTION IN OWN SHARES
Mar 2, 2026
5.1 MB
6-K
Mar 2, 2026
0001654954-26-001733TOTAL VOTING RIGHTS
Mar 2, 2026
20.0 KB
6-K
Feb 27, 2026
0001654954-26-001650DIRECTOR/PDMR SHAREHOLDING
Feb 27, 2026
33.1 KB
6-K
Feb 27, 2026
0001654954-26-001625TRANSACTION IN OWN SHARES
Feb 27, 2026
7.1 MB
6-K
Feb 26, 2026
0001654954-26-001580LINERIXIBAT ACCEPTED FOR PRIORITY REVIEW IN CHINA
Feb 26, 2026
40.0 KB
6-K
Feb 26, 2026
0001654954-26-001578BEPIROVIRSEN ACCEPTED FOR JAPAN REGULATORY REVIEW
Feb 26, 2026
45.0 KB
6-K
Feb 26, 2026
0001654954-26-001575TRANSACTION IN OWN SHARES
Feb 26, 2026
5.2 MB
6-K
Feb 25, 2026
0001654954-26-001551DIRECTOR/PDMR SHAREHOLDING
Feb 25, 2026
33.0 KB
6-K
Feb 25, 2026
0001654954-26-001547DIRECTOR/PDMR SHAREHOLDING
Feb 25, 2026
33.4 KB
6-K
Feb 25, 2026
0001654954-26-001533GSK ENTERS AGREEMENT TO ACQUIRE 35PHARMA
Feb 25, 2026
40.7 KB
6-K
Feb 25, 2026
0001654954-26-001531TRANSACTION IN OWN SHARES
Feb 25, 2026
5.2 MB
6-K
Feb 24, 2026
0001654954-26-001495DIRECTOR/PDMR SHAREHOLDING
Feb 24, 2026
51.9 KB
6-K
Feb 24, 2026
0001654954-26-001477TRANSACTION IN OWN SHARES
Feb 24, 2026
5.4 MB
SC TO-T/A
Feb 24, 2026
0001193125-26-065083SC TO-T/A
—
23.7 KB